NO952825D0 - Farmasöytisk preparat - Google Patents
Farmasöytisk preparatInfo
- Publication number
- NO952825D0 NO952825D0 NO952825A NO952825A NO952825D0 NO 952825 D0 NO952825 D0 NO 952825D0 NO 952825 A NO952825 A NO 952825A NO 952825 A NO952825 A NO 952825A NO 952825 D0 NO952825 D0 NO 952825D0
- Authority
- NO
- Norway
- Prior art keywords
- nizatidine
- nitro
- iii
- ethenediamine
- contg
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 abstract 7
- 229960004872 nizatidine Drugs 0.000 abstract 7
- BSGRLBPZSRZQOR-UHFFFAOYSA-N ethene-1,1-diamine Chemical compound NC(N)=C BSGRLBPZSRZQOR-UHFFFAOYSA-N 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- SGXXNSQHWDMGGP-UHFFFAOYSA-N nizatidine Chemical group [O-][N+](=O)C=C(NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/298,486 US5470865A (en) | 1994-08-30 | 1994-08-30 | Pharmaceutical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952825D0 true NO952825D0 (no) | 1995-07-17 |
| NO952825L NO952825L (no) | 1996-03-01 |
Family
ID=23150736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952825A NO952825L (no) | 1994-08-30 | 1995-07-17 | Farmasöytisk preparat |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5470865A (no) |
| EP (1) | EP0704214B1 (no) |
| JP (1) | JPH0892087A (no) |
| KR (1) | KR960006921A (no) |
| CN (1) | CN1127635A (no) |
| AT (1) | ATE192039T1 (no) |
| AU (1) | AU700488B2 (no) |
| BR (1) | BR9503832A (no) |
| CA (1) | CA2157240A1 (no) |
| CO (1) | CO4410183A1 (no) |
| CZ (1) | CZ189395A3 (no) |
| DE (1) | DE69516475T2 (no) |
| ES (1) | ES2145221T3 (no) |
| FI (1) | FI954050A (no) |
| HU (1) | HUT72672A (no) |
| IL (1) | IL115012A0 (no) |
| NO (1) | NO952825L (no) |
| NZ (1) | NZ272833A (no) |
| PE (1) | PE33696A1 (no) |
| PH (1) | PH31452A (no) |
| PL (1) | PL310207A1 (no) |
| TR (1) | TR199500885A2 (no) |
| YU (1) | YU57495A (no) |
| ZA (1) | ZA957281B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010068707A (ko) * | 2000-01-07 | 2001-07-23 | 최용준 | 시계줄 |
| JP2001240534A (ja) * | 2000-02-29 | 2001-09-04 | Bio Kagaku Kk | 液状組成物 |
| KR102178793B1 (ko) * | 2019-04-17 | 2020-11-13 | 황용석 | 순금 장식연결구 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4760075A (en) * | 1980-10-02 | 1988-07-26 | Eli Lilly And Company | N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds |
| US4375547A (en) * | 1980-10-02 | 1983-03-01 | Eli Lilly And Company | N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine |
| US4382090A (en) * | 1980-10-02 | 1983-05-03 | Eli Lilly And Company | N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds |
| US4904792A (en) * | 1980-10-02 | 1990-02-27 | Eli Lilly And Company | N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds |
| ZA84869B (en) * | 1983-02-07 | 1985-09-25 | Lilly Co Eli | The synthesis of nizatidine |
| US4587344A (en) * | 1983-02-07 | 1986-05-06 | Eli Lilly And Company | Isothiourea synthesis process |
| IL80961A0 (en) * | 1985-12-18 | 1987-03-31 | Lilly Co Eli | Synthesis of nizatidine |
| US4777260A (en) * | 1985-12-18 | 1988-10-11 | Eli Lilly And Company | Synthesis of nizatidine intermediate |
| US4857344A (en) | 1986-12-31 | 1989-08-15 | Del Monte Corporation | Method for treating pineapple to inhibit browning |
| ES2053462T3 (es) * | 1987-04-06 | 1994-08-01 | Heumann Pharma Gmbh & Co | Procedimiento para la produccion de derivados de nitroetano. |
| DE68910308D1 (de) * | 1989-05-10 | 1993-12-02 | Council Scient Ind Res | Verfahren zur Herstellung von 1-amino-substituierten 1-thio-substituierten 2-Nitro Alkenen. |
| US5075114A (en) * | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
| CA2055661A1 (en) * | 1990-12-21 | 1992-06-22 | Manley A. Paulos | Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation |
| US5334725A (en) * | 1991-05-21 | 1994-08-02 | Eli Lilly And Company | 2-aminomethyl-4-exomethylenethiazoline epoxides |
| US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
-
1994
- 1994-08-30 US US08/298,486 patent/US5470865A/en not_active Expired - Lifetime
-
1995
- 1995-07-14 CO CO95031236A patent/CO4410183A1/es unknown
- 1995-07-14 PE PE1995273860A patent/PE33696A1/es not_active Application Discontinuation
- 1995-07-17 NO NO952825A patent/NO952825L/no unknown
- 1995-07-20 CZ CZ951893A patent/CZ189395A3/cs unknown
- 1995-07-20 TR TR95/00885A patent/TR199500885A2/xx unknown
- 1995-08-21 IL IL11501295A patent/IL115012A0/xx unknown
- 1995-08-23 NZ NZ272833A patent/NZ272833A/en unknown
- 1995-08-28 PL PL95310207A patent/PL310207A1/xx unknown
- 1995-08-29 KR KR1019950027004A patent/KR960006921A/ko not_active Application Discontinuation
- 1995-08-29 FI FI954050A patent/FI954050A/fi unknown
- 1995-08-29 YU YU57495A patent/YU57495A/sh unknown
- 1995-08-29 BR BR9503832A patent/BR9503832A/pt not_active Application Discontinuation
- 1995-08-29 AU AU30334/95A patent/AU700488B2/en not_active Ceased
- 1995-08-30 CN CN95116919A patent/CN1127635A/zh active Pending
- 1995-08-30 CA CA002157240A patent/CA2157240A1/en not_active Abandoned
- 1995-08-30 ES ES95306049T patent/ES2145221T3/es not_active Expired - Lifetime
- 1995-08-30 HU HU9502542A patent/HUT72672A/hu unknown
- 1995-08-30 PH PH51217A patent/PH31452A/en unknown
- 1995-08-30 AT AT95306049T patent/ATE192039T1/de not_active IP Right Cessation
- 1995-08-30 ZA ZA957281A patent/ZA957281B/xx unknown
- 1995-08-30 EP EP95306049A patent/EP0704214B1/en not_active Expired - Lifetime
- 1995-08-30 DE DE69516475T patent/DE69516475T2/de not_active Expired - Fee Related
- 1995-08-30 JP JP7221564A patent/JPH0892087A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI954050A (fi) | 1996-03-02 |
| US5470865A (en) | 1995-11-28 |
| JPH0892087A (ja) | 1996-04-09 |
| ES2145221T3 (es) | 2000-07-01 |
| YU57495A (sh) | 1999-07-28 |
| IL115012A0 (en) | 1996-01-31 |
| DE69516475T2 (de) | 2000-09-28 |
| CN1127635A (zh) | 1996-07-31 |
| AU700488B2 (en) | 1999-01-07 |
| CA2157240A1 (en) | 1996-03-01 |
| ATE192039T1 (de) | 2000-05-15 |
| EP0704214B1 (en) | 2000-04-26 |
| DE69516475D1 (de) | 2000-05-31 |
| FI954050A0 (fi) | 1995-08-29 |
| EP0704214A1 (en) | 1996-04-03 |
| HUT72672A (en) | 1996-05-28 |
| PE33696A1 (es) | 1996-08-29 |
| ZA957281B (en) | 1997-02-28 |
| PH31452A (en) | 1998-11-03 |
| CZ189395A3 (en) | 1996-03-13 |
| NZ272833A (en) | 1997-04-24 |
| KR960006921A (ko) | 1996-03-22 |
| PL310207A1 (en) | 1996-03-04 |
| BR9503832A (pt) | 1996-09-10 |
| NO952825L (no) | 1996-03-01 |
| HU9502542D0 (en) | 1995-10-30 |
| AU3033495A (en) | 1996-03-14 |
| TR199500885A2 (tr) | 1996-06-21 |
| CO4410183A1 (es) | 1997-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR970005014A (ko) | 특정 물리적 형태의 n-[4-[5-아미노-1-메틸인돌-3-일-메틸]-3-메톡시벤조일]-2-메틸-벤젠설폰아미드 화합물 및 이의 제조 방법 | |
| SE8001736L (sv) | Indolerivat med terapeutisk verkan jemte sett for deras framstellning | |
| NL193694B (nl) | 5 Gesubstitueerde 3-(aminoalkyl)-1H-indoolderivaten met werking tegen migraine en farmaceutisch preparaat daarvan. | |
| RU93053493A (ru) | Сульфатная соль (2:1)-3-[2-(диметиламино)этил]-n-метил-1н-индол-5-метансульфонамида и ее фармацевтически приемлемые сольваты, способ их получения, фармацевтические композиции на их основе, их применение в терапии, способ лечения головной боли | |
| NO952825D0 (no) | Farmasöytisk preparat | |
| RU93005302A (ru) | 5,6-дизамещенные-3-пиридилметиламмонийгалоидные соединения, применяемые для получения 5-(замещенный метил)-2,3-пиридинкарбоновых кислот | |
| FR2523965B1 (fr) | (benzimidazolyl-1)-1, n-((hydroxy-4 methoxy-3 phenyl)-2 hydroxy-2 ethyl) amino-3 butane et ses sels a activite b-adrenergique, leurs applications therapeutiques, et procede pour les preparer | |
| IT1095415B (it) | Processo per la produzione di una benzamide otticamente attiva,benzamide otticamente attiva cosi'ottenuta e composizioni | |
| DE69600793T2 (de) | Verfahren zur herstellung von cyclopropancarboxaldehyd | |
| RU96115481A (ru) | Способ лечения деформирующего остеоартроза крупных суставов | |
| SE9400524L (sv) | Energipreparat | |
| NO159448C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin. | |
| EP0342565A3 (de) | Verwendung des Thiazol-Derivates Tiprotimod zur Herstellung eines Mittels zur Therapie von Virusinfektionen | |
| NO910426L (no) | Fremgangsmaate for opploesning av cis 3-amino-4-(2-(2-furyl)et-1-yl)-1-metoksykarbonylmetyl-azetidin-2-on. | |
| FI972528A (fi) | Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi | |
| DK158033C (da) | Fremgangsmaade til afgiftning af e.coli neurotoxin og fremgangsmaade til fremstilling af en vaccine mod oedemsygdom hos smaagrise | |
| SU814997A1 (ru) | Способ обработки бетонных изделий | |
| KR890012940A (ko) | 1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논, 이의 제조방법 및 치료적 용도 | |
| DK525980A (da) | N-(3-(!-3"-oxapentamethylenaminoaethylidenamino)-2,4,6-trijodbenzoyl)-betaamino-alfa-methylpropiontril og en fremgangsmaade til dets fremstilling | |
| SE8601421L (sv) | Harbehandlingsmedel och forfarande for kosmetisk behandling av har och harbottnar | |
| SE9000658L (sv) | Medel foer behandling av soemnapne | |
| DK157494C (da) | Fremgangsmaade til fremstilling af n-(2(((5-((dimethylamino)-methyl)-2-furanyl)methyl)thio)ethyl)-n'(3,4-methylendioxybenzyl)-2-nitro-1,1-ethendiamin | |
| IT1169237B (it) | Metodo per l'isolamento e la purificazione della n-(2-(((5-(dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1-etendiamina | |
| IT1167489B (it) | Procedimento per la preparazione della n-(2-(((5-(dimetilamino)-metil-2-furil)-metil)-tio)-)n'-metil-2-nitro-1,1-etilendiamina | |
| IT7827747A0 (it) | Processo per la preparazione di esteri non simmetrici di acidi 1,4-diidropiridin-dicarbossilici eloro impiego come farmaci. |